Can Mounjaro Cause Nose Bleeds? What the Clinical Evidence Shows

Step 1: Check what Mounjaro's official UK prescribing information actually lists

The first place to look is the Summary of Product Characteristics published on the Electronic Medicines Compendium (eMC), which is the authoritative reference for every licensed UK medicine. Epistaxis, the clinical term for nose bleeds, is not listed there as a side effect of tirzepatide at any frequency category, common, uncommon, rare or very rare.

The same holds for the data from the SURMOUNT programme. SURMOUNT-1 ran for 72 weeks across thousands of adults and collected adverse events systematically; nasal bleeding was not flagged as a pattern that distinguished tirzepatide from placebo. That absence matters. It means that if you are experiencing nose bleeds while using Mounjaro, the medicine is unlikely to be the direct pharmacological cause.

A question our prescribers hear most weeks is whether GLP-1 or dual-agonist medicines affect blood vessels or clotting. The short answer is that tirzepatide's mechanism, activating GIP and GLP-1 receptors to regulate appetite and blood glucose, does not involve the pathways that govern nasal vascular integrity or platelet function. There is no pharmacological mechanism that would make nose bleeds an expected effect.

For a fuller picture of tirzepatide's known side-effect profile, the tirzepatide overview on this site sets out what the clinical programme found.

Step 2: Understand the indirect pathways that could plausibly connect them

Just because something is not a direct effect does not mean the timing is always coincidental. Mounjaro's most common side effects are gastrointestinal: nausea, vomiting, diarrhoea and reduced appetite are well-documented, particularly after starting treatment or after a dose increase. Vomiting repeatedly raises pressure in the head and face; straining with nausea can rupture small surface vessels inside the nasal passages. This is a well-understood mechanical effect, not unique to Mounjaro.

Reduced fluid and food intake is another plausible link. When appetite falls sharply, some people drink less than usual, and dehydration dries out the mucous membranes lining the nose. Dry, fragile mucosa bleeds more easily, especially in centrally-heated homes during winter or in air-conditioned environments. This is not something the medicine causes directly; it is a downstream consequence of eating and drinking less.

Separately, anyone with high blood pressure should note that uncontrolled hypertension is a recognised cause of nose bleeds. Mounjaro is sometimes prescribed alongside existing cardiovascular risk factors; the blood pressure itself, not the injection, would be the relevant variable in those cases.

Curious about the broader question of whether tirzepatide can affect bleeding in other ways? The guide to Mounjaro and bleeding covers related queries in more detail.

Step 3: Know when a nose bleed needs more than a cold flannel

Most nose bleeds resolve within ten to fifteen minutes of applying gentle pressure. For people on Mounjaro, a one-off bleed with an obvious cause, a dry environment, a minor knock, seasonal hayfever, is unlikely to require anything more than basic first aid.

Contact your GP or prescriber if nose bleeds are frequent, prolonged (lasting more than twenty minutes despite pressure), or occur alongside other unexpected bleeding such as bruising easily or blood in urine or stools. That combination warrants investigation independent of your weight-management medicine. Our dedicated page on Mounjaro nosebleeds goes into more detail on when to seek help and what questions to raise with your prescriber. The MHRA Yellow Card scheme allows patients and healthcare professionals to report suspected side effects of any medicine, including events that may or may not be related; reporting even uncertain associations helps regulators spot genuine patterns over time.

If you are worried about any new symptom that appeared after starting or increasing your dose, the right step is to speak to your prescriber. Stopping or changing your dose without clinical advice is not recommended; changes to the tirzepatide schedule should always be made in consultation with the person who prescribed it. For context on how Mounjaro fits into the wider landscape of licensed UK weight-loss treatments, the weight-loss treatment overview is a useful reference.

Step 4: Practical steps to reduce nasal dryness while on treatment

Since dehydration is the most plausible indirect link, staying well hydrated is both sensible and supported by general clinical advice for anyone on a GLP-1 or dual-agonist medicine. NHS guidance on weight-management medicines highlights the importance of maintaining adequate fluid intake, particularly when GI side effects are reducing appetite.

Saline nasal sprays can help keep mucosa moist in dry environments and are available without a prescription. A humidifier in a bedroom overnight is worth considering for anyone prone to dry nasal passages. These are general measures; whether they are appropriate alongside your specific treatment plan is something your prescriber or pharmacist can advise on.

The Mounjaro information hub covers the full side-effect picture, storage, eligibility and what the clinical trials found, all drawn from UK licensed sources. And if you have questions about cost or access, the Mounjaro pricing guide explains how private treatment is structured, including what is covered in a single transparent fee.

If you are considering starting treatment and want a clinical assessment from a GPhC-registered prescriber, start your free consultation with our team, who offer Mounjaro in Leeds and can match you with a prescriber suited to your needs via our Mounjaro Leeds service.